Literature DB >> 24216548

Recognition of complications after pancreaticoduodenectomy for cancer determines inpatient mortality.

Evan S Glazer1, Albert Amini, Tun Jie, Rainer W G Gruessner, Robert S Krouse, Evan S Ong.   

Abstract

CONTEXT: While perioperative mortality after pancreaticoduodenectomy is decreasing, key factors remain to be elucidated.
OBJECTIVE: The purpose of this study was to investigate inpatient mortality after pancreaticoduodenectomy in the Nationwide Inpatient Sample (NIS), a representative inpatient database in the USA.
METHODS: Patient discharge data (diagnostic and procedure codes) and hospital characteristics were investigated for years 2009 and 2010. The inclusion criteria were a procedure code for pancreaticoduodenectomy, elective procedure, and a pancreatic or peripancreatic cancer diagnosis. Chi-square test determined statistical significance. A logistic regression model for mortality was created from significant variables.
RESULTS: Two-thousand and 958 patients were identified with an average age of 65±12 years; 53% were male. The mean length of stay was 15±12 days with a mortality of 4% and a complication rate of 57%. Eighty-six percent of pancreaticoduodenectomy occurred in teaching hospitals. Pancreaticoduodenectomy performed in teaching hospitals in the first half of the academic year were associated with higher mortality than in the latter half (5.5% vs. 3.4%, P=0.005). On logistic regression analysis, non-surgical complications are the largest predictor of death (P<0.001) while operations in the latter half of the academic year are associated with decreased mortality (P<0.01).
CONCLUSIONS: The timing of pancreaticoduodenectomy for cancer remained more predictive of mortality than age or length of stay; only complications were more predictive of death than time of year. This suggests that there remains a clinically and statistically significant learning curve for trainees in identifying complications; further study is needed to prove that identification of complications leads to a decrease in mortality rate by taking corrective actions.

Entities:  

Mesh:

Year:  2013        PMID: 24216548     DOI: 10.6092/1590-8577/1883

Source DB:  PubMed          Journal:  JOP        ISSN: 1590-8577


  6 in total

1.  Tobacco Smoking Associated With Increased Anastomotic Disruption Following Pancreaticoduodenectomy.

Authors:  Noah S Rozich; Alessandra Landmann; Casey S Butler; Morgan M Bonds; Laura E Fischer; Russell G Postier; Katherine T Morris
Journal:  J Surg Res       Date:  2018-08-31       Impact factor: 2.192

2.  Age and Obesity are Independent Predictors of Bile Duct Injuries in Patients Undergoing Laparoscopic Cholecystectomy.

Authors:  Hassan Aziz; Viraj Pandit; Bellal Joseph; Tun Jie; Evan Ong
Journal:  World J Surg       Date:  2015-07       Impact factor: 3.352

3.  Preoperative Nutritional Assessment Using the Controlling Nutritional Status Score to Predict Pancreatic Fistula After Pancreaticoduodenectomy.

Authors:  Masashi Utsumi; Hideki Aoki; Seichi Nagahisa; Seitaro Nishimura; Yuta Une; Yuji Kimura; Fumitaka Taniguchi; Takashi Arata; Koh Katsuda; Kohji Tanakaya
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

4.  Analysis of risk factors for postoperative pancreatic fistula following pancreaticoduodenectomy.

Authors:  Qi-Yu Liu; Wen-Zhi Zhang; Hong-Tian Xia; Jian-Jun Leng; Tao Wan; Bin Liang; Tao Yang; Jia-Hong Dong
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

5.  Increased neutrophil-to-lymphocyte ratio after neoadjuvant therapy is associated with worse survival after resection of borderline resectable pancreatic ductal adenocarcinoma.

Authors:  Evan S Glazer; Omar M Rashid; Jose M Pimiento; Pamela J Hodul; Mokenge P Malafa
Journal:  Surgery       Date:  2016-07-20       Impact factor: 3.982

6.  Evaluating IPMN and pancreatic carcinoma utilizing quantitative histopathology.

Authors:  Evan S Glazer; Hao Helen Zhang; Kimberly A Hill; Charmi Patel; Stephanie T Kha; Michael L Yozwiak; Hubert Bartels; Nellie N Nafissi; Joseph C Watkins; David S Alberts; Robert S Krouse
Journal:  Cancer Med       Date:  2016-09-26       Impact factor: 4.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.